Real-World Tirzepatide Effectiveness and Dosing in Obesity Patients

Obesity is a complex chronic disease with significant health implications, and novel pharmacotherapies like tirzepatide have emerged as powerful treatment options. While controlled clinical trials have demonstrated remarkable efficacy, with some participants achieving up to 21% body weight reduction, there is a recognized gap in understanding its real-world effectiveness and optimal dosing patterns in routine clinical practice. This knowledge gap is crucial for translating trial results into broader patient benefits.